Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients.
Tamburino C, Ciriminna S, Barbagallo R, Galassi AR, Ussia G, Capranzano P, Tagliareni F, Tolaro S, Nicosia A, Stabile A, Grassi R, Fiscella A, Patti A, Saccone G. Tamburino C, et al. Among authors: capranzano p. J Cardiovasc Med (Hagerstown). 2008 Feb;9(2):161-8. doi: 10.2459/JCM.0b013e32815aa7d1. J Cardiovasc Med (Hagerstown). 2008. PMID: 18192809
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
Angiolillo DJ, Capranzano P, Goto S, Aslam M, Desai B, Charlton RK, Suzuki Y, Box LC, Shoemaker SB, Zenni MM, Guzman LA, Bass TA. Angiolillo DJ, et al. Among authors: capranzano p. Eur Heart J. 2008 Sep;29(18):2202-11. doi: 10.1093/eurheartj/ehn287. Epub 2008 Jun 21. Eur Heart J. 2008. PMID: 18567918 Clinical Trial.
Pharmacology of emerging novel platelet inhibitors.
Angiolillo DJ, Capranzano P. Angiolillo DJ, et al. Among authors: capranzano p. Am Heart J. 2008 Aug;156(2 Suppl):S10-5. doi: 10.1016/j.ahj.2008.06.004. Am Heart J. 2008. PMID: 18657681 Review.
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA. Tamburino C, et al. Among authors: capranzano p. Catheter Cardiovasc Interv. 2008 Oct 1;72(4):448-56. doi: 10.1002/ccd.21666. Catheter Cardiovasc Interv. 2008. PMID: 18814218
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry.
Tamburino C, Di Salvo ME, Capodanno D, Capranzano P, Parisi R, Mirabella F, Scardaci F, Ussia G, Galassi AR, Fiscella D, Mehran R, Dangas G. Tamburino C, et al. Among authors: capranzano p. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):243-8. doi: 10.1002/ccd.21750. Catheter Cardiovasc Interv. 2009. PMID: 19156896
219 results